Literature DB >> 34219921

Screening for SARS-CoV-2 via PCR and serological testing in asymptomatic healthcare workers.

Taimur Safder1, Peter A McCullough1,2,3,4, Kevin R Wheelan1,3,4, Gelareh Rahimi1, Sandra Zurawski5, Gerard Zurawski5, Jinghua Gu5, Xuan Wang5, Uthra Balaji5, Mezgebe Berhe2,3,6, Laura Clariday1, Rebecca Baker1, Kristen Chionh1, Giselle Carino1, Uriel S Sandkovsky3,6.   

Abstract

The prevalence and seroconversion rate of SARS-CoV-2 infection among asymptomatic health care workers in the US is unclear. Our study utilized real-time polymerase chain reaction (RT-PCR) SARS-CoV-2 testing and serological evaluation to detect IgG antibodies specific to SARS-CoV-2 antigens in asymptomatic health care workers. A total of 197 subjects with a mean age of 35 years were recruited into the study. While most (67%) reported prolonged contact with known COVID-19 patients, only 8 (4.2%) tested positive on RT-PCR and 23 (11.7%) had detectable levels of IgG antibody to SARS-CoV-2. Out of 19 subjects with detectable IgG antibody at week 1, 11 (57.9%) lost their antibody response by week 3. No statistically significant difference was found in baseline characteristics or exposure status between subjects with positive and negative results on RT-PCR or antibody positivity. In conclusion, we found a low incidence of PCR positivity for SARS-CoV-2 in a high-risk group. This likely demonstrates the effectiveness of proper personal protective equipment use and low transmission risk in health care settings. The detectable IgG antibody titer was low, and a significant portion of subjects lost their antibody response on repeat testing. This may mean that antibody response in asymptomatic patients is categorically different than in symptomatic hospitalized patients with COVID-19.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Antibody; COVID-19; PCR testing; SARS-CoV-2; healthcare workers; serology

Year:  2021        PMID: 34219921      PMCID: PMC8224198          DOI: 10.1080/08998280.2021.1895959

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  9 in total

1.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.

Authors:  Quan-Xin Long; Xiao-Jun Tang; Qiu-Lin Shi; Qin Li; Hai-Jun Deng; Jun Yuan; Jie-Li Hu; Wei Xu; Yong Zhang; Fa-Jin Lv; Kun Su; Fan Zhang; Jiang Gong; Bo Wu; Xia-Mao Liu; Jin-Jing Li; Jing-Fu Qiu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-06-18       Impact factor: 53.440

2.  Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-04-15       Impact factor: 53.440

3.  Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium.

Authors:  Deborah Steensels; Els Oris; Laura Coninx; Dieter Nuyens; Marie-Luce Delforge; Pieter Vermeersch; Line Heylen
Journal:  JAMA       Date:  2020-07-14       Impact factor: 56.272

4.  Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic.

Authors:  Mario Poljak; Miša Korva; Nataša Knap Gašper; Kristina Fujs Komloš; Martin Sagadin; Tina Uršič; Tatjana Avšič Županc; Miroslav Petrovec
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

5.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.

Authors:  Johannes Korth; Benjamin Wilde; Sebastian Dolff; Olympia E Anastasiou; Adalbert Krawczyk; Michael Jahn; Sebastian Cordes; Birgit Ross; Stefan Esser; Monika Lindemann; Andreas Kribben; Ulf Dittmer; Oliver Witzke; Anke Herrmann
Journal:  J Clin Virol       Date:  2020-05-13       Impact factor: 3.168

6.  COVID-19: PCR screening of asymptomatic health-care workers at London hospital.

Authors:  Thomas A Treibel; Charlotte Manisty; Maudrian Burton; Áine McKnight; Jonathan Lambourne; João B Augusto; Xosé Couto-Parada; Teresa Cutino-Moguel; Mahdad Noursadeghi; James C Moon
Journal:  Lancet       Date:  2020-05-08       Impact factor: 79.321

7.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

8.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

9.  Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.

Authors:  William B Stubblefield; H Keipp Talbot; Leora R Feldstein; Mark W Tenforde; Mohammed Ata Ur Rasheed; Lisa Mills; Sandra N Lester; Brandi Freeman; Natalie J Thornburg; Ian D Jones; Michael J Ward; Christopher J Lindsell; Adrienne Baughman; Natasha Halasa; Carlos G Grijalva; Todd W Rice; Manish M Patel; Wesley H Self
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.